Fondastop C Cream is a potent topical formulation combining Ofloxacin (0.75% w/w), Ornidazole (2% w/w), Itraconazole (1% w/w), and Clobetasol (0.05% w/w) designed to effectively treat mixed infections involving bacterial, protozoal, and fungal pathogens, along with inflammatory skin conditions. Ofloxacin, a broad-spectrum fluoroquinolone antibiotic, targets and eradicates susceptible bacterial strains, while Ornidazole provides antiprotozoal and antibacterial activity against anaerobic organisms. Itraconazole, a triazole antifungal agent, combats dermatophytic and yeast infections by inhibiting fungal cell membrane synthesis. Clobetasol, a highly potent corticosteroid, reduces inflammation, itching, and redness associated with various dermatoses. This combination is particularly useful in managing complicated skin infections where multiple pathogens coexist, accompanied by significant inflammatory responses. Fondastop C Cream should be applied topically as directed by a healthcare professional, typically on the affected area once or twice daily. It is essential to avoid prolonged use due to the potent steroid content, which may cause skin thinning or other adverse effects. Patients should consult a physician before use, especially if pregnant, breastfeeding, or having hypersensitivity to any component. Proper adherence to prescribed duration ensures optimal therapeutic outcomes while minimizing potential side effects.